Pulmonary fibrosis is a chronic and progressive lung disease characterized by the scarring of lung tissue, which makes it difficult for the lungs to function properly. The scarring, also known as fibrosis, makes the lung tissue thick and stiff, leading to decreased lung capacity and impaired oxygen exchange. As a result, individuals with pulmonary fibrosis often experience symptoms such as:
Pulmonary fibrosis can develop slowly over time (known as idiopathic pulmonary fibrosis or IPF), or it can be caused by various factors, including:
involves a combination of medical history review, physical examinations, pulmonary function tests, imaging studies (such as chest X-rays or CT scans), and sometimes lung biopsies to confirm the presence of fibrosis and determine its underlying cause.
Treatment for pulmonary fibrosis aims to slow the progression of the disease, manage symptoms, and improve the patient’s quality of life. Common treatment approaches include:
Individuals with pulmonary fibrosis need to work closely with their healthcare team to develop a personalized treatment plan and to monitor the progression of the disease. While there is currently no cure for pulmonary fibrosis, early diagnosis, and appropriate management can help improve the patient’s quality of life and slow the progression of the disease.